Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Eurocine Vaccines AB ("Eurocine Vaccines" or the "Company") has today selected Biovian Oy, Turku, Finland, ("Biovian") as the contract developer for...
This week, dosing was completed according to plan in the second clinical study with Immunose™ FLU, developed with the aim to become a modern and...
Eurocine Vaccines strengthens the organization with necessary competence, not only to prepare for further development of its first product, the nasal ...
Eurocine Vaccines expects results from the ongoing immunological analyses in June/July 2017. The samples presently being analyzed were collected...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.